COMMUNIQUÉS West-GlobeNewswire

Ogilvy CommonHealth Worldwide promotes Paula Huntzinger to chief talent officer
19/07/2018
PARSIPPANY, N.J., July 19, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide (OCHWW; www.ogilvychww.com ), a WPP Health & Wellness company (NYSE:WPP), ( www.wpp.com ), today announced the promotion of Paula [...]
Organic & Natural Health Association and GrassrootsHealth Win NBJ Education Award for Nutrient Power Campaign
19/07/2018
RANCHO PALOS VERDES, Calif., July 19, 2018 (GLOBE NEWSWIRE) -- Organic & Natural Health Association along with research partner, GrassrootsHealth , was awarded the Nutrition Business Journal’s 2017 award for [...]
Establishment Labs Celebrates Initial Public Offering on the Nasdaq Stock Market
19/07/2018
NEW YORK, July 19, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ:ESTA) today announced that the company’s common stock commenced trading on the Nasdaq Stock Market under the trading symbol “ESTA” [...]
American College of Rheumatology Responds to the CY 2019 Physician Fee Schedule and Quality Payment Program Proposed Rules
19/07/2018
Statement from ACR President David Daikh regarding the 2019 Physician Fee Schedule and Quality Payment Program proposed rules: Atlanta, July 19, 2018 (GLOBE NEWSWIRE) -- “While we are encouraged by CMS’ continued focus [...]
Repligen to Report Second Quarter 2018 Financial Results
19/07/2018
Webcast and Conference Call to Be Held Thursday, August 2, 2018 at 8:30 a.m. EDT WALTHAM, Mass., July 19, 2018 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its [...]
ThromboGenics Reports Day 150 Topline Data from its Phase 1/2 Clinical Study evaluating THR-317 (anti-PlGF) for the Treatment of Diabetic Macular Edema (DME)
19/07/2018
Press release Study results confirm safety and tolerability of THR-317 for intra-ocular use, and show improvement in visual acuity for up to 90 days after last injection Leuven, Belgium, 19 July 2018 - ThromboGenics NV [...]
Invitation to Idorsia's half year financial results 2018 webcast and conference call
19/07/2018
Date: Tuesday, July 24, 2018 Time: 14:00 CEST / 13:00 BST / 08:00 EDT The call will start with presentations by senior management, followed by a Q&A session (live access to the speakers). To support your [...]
Medtronic Clinical Trial to Evaluate ECG Belt for Optimizing Heart Failure Therapy
19/07/2018
DUBLIN - July 19, 2018 - Medtronic plc (NYSE: MDT) today announced first enrollments in a new clinical trial evaluating the ECG (electrocardiography) Belt Research System (ECG Belt) as a diagnostic tool for optimizing [...]
Respinova Wins Chiesi Spain and Richi Entrepreneurs Second Call
19/07/2018
BARCELONA, Spain, July 19, 2018 (GLOBE NEWSWIRE) -- Respinova, a Herzliya, Israel-based clinical-stage medical device company developing the novel, non-invasive PulseHalerä technology, today announced that it has won [...]
LHC Group Announces Second Quarter 2018 Earnings Release and Conference Call Dates
19/07/2018
LAFAYETTE, La., July 19, 2018 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ:LHCG) today announced details for the release of its results for the second quarter and six months ended June 30, 2018. LHC Group plans to issue [...]
Twinlab Consolidated Holdings Names Anthony Zolezzi CEO
19/07/2018
Boca Raton, Fla., July 19, 2018 (GLOBE NEWSWIRE) -- Anthony Zolezzi has been named chief executive officer of prominent nutritional and nutrient supplement company, Twinlab Consolidated Holdings, Inc. (OTCPK:TLCC) ("TCC [...]
CrownBio Supports Excellence in Translational Research with Grant Award that Funds Innovative PDX Model Development in Immuno-Oncology
19/07/2018
"Cancer Research Center of Lyon iPS novel PDX models formulate new immune cell focused strategies” SAN DIEGO, July 19, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company [...]
CFN Media: Koios Expands into Cannabis Functional Beverages
19/07/2018
SEATTLE, July 19, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]
EHNAC Executive Director Addresses TEFCA and Where Industry is Heading in Achieving Interoperability
19/07/2018
FARMINGTON, Conn., July 19, 2018 (GLOBE NEWSWIRE) -- In an effort to improve interoperability and reduce administrative burden across the healthcare industry, the Department of Health and Human Services’ (HHS) Office of [...]
BioStem Technologies (BSEM) Subsidiary Nesvik Pharmaceuticals Announces the Completion of An Asset Purchase of Multiple New Drug Compounds and Launches Joint Development Venture with CCM Pharma Solutions
19/07/2018
Pompano Beach, FL, July 19, 2018 (GLOBE NEWSWIRE) -- Nesvik Pharmaceuticals (f/k/a BioStem Pharmaceuticals), a subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life [...]
Oncobiologics Completes Exchange of Series A Convertible Preferred Stock for Newly Created Series A-1 Convertible Preferred Stock
19/07/2018
CRANBURY, N.J., July 19, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (Nasdaq:ONS) today announced that, on July 18, 2018, the Company completed the exchange of an aggregate of 58,735 shares of voting Series A [...]
Harvard Bioscience Schedules Second Quarter 2018 Conference Call for July 26 at 4:30 PM ET
19/07/2018
HOLLISTON, Mass., July 19, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for [...]
Golden Leaf Holdings Provides Progress Update for Medical Marijuana Group
19/07/2018
Canadian subsidiary secures first cannabis harvest and submits application to Health Canada for final sales license inspection TORONTO, July 19, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “ [...]
Devonian Health Group announces Non-Brokered Financing by way of a private placement of Convertible Debenture
19/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN THE UNITED STATES. Aspri Pharma Canada Inc. acts as lead subscriber Unsecured Convertible Debentures convertible at a price of $0.75 Interest at a [...]

Pages